Pitango offices at Akershtein Towers, Herzliya | |
Type | Private |
---|---|
Industry | Venture capital |
Founded | 1993 |
Founder | Rami Kalish and Chemi Peres |
Headquarters | , |
AUM | USD $2.8 billion |
Number of employees | ~40 |
Website | www |
Pitango VC, established in 1993, is Israel's largest venture capital fund with over $2.8 billion under management. [ citation needed ] Pitango VC invests through three dedicated funds, Pitango First (early-stage investments), Pitango HealthTech (HealthTech investments), and Pitango Growth (growth investments). Pitango invests in startups around the world, in domains such as Vertical SaaS, Digital Health, Deep Tech, FinTech & InsureTech, Devops, Generative AI, Web3, and FoodTech.
With two offices in Israel (Herzliya and Sarona), Pitango currently manages several venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies with its investors including Time Warner, Citigroup, Eastman Kodak, Deutsche Bank and HarbourVest Partners. [1]
The fund was founded as Polaris Venture Capital in 1993 by Rami Kalish, as part of a government initiative named the Yozma program ("Initiative" in Hebrew); which offered attractive tax incentives to any foreign venture-capital investments in Israel and offered to double any investment with funds from the government. [2]
In 1996, Kalish was joined by Chemi Peres, son of former Israeli president Shimon Peres, to create Polaris Fund II, which raised more than $100 million. Polaris II invested in 35 high-tech companies. Some were partially funded by another Israeli VC firm, Eucalyptus Ventures. When the investments proved successful, Polaris II and Eucalyptus merged into Fund III in early 2000. [1]
In 2001, Polaris Venture Capital changed its name to Pitango Venture Capital, to avoid confusion with Boston based Polaris Venture Partners. Although the Boston firm was founded in 1996, which was after Pitango was founded, the Israeli firm decided to change its name. Pitango takes its name from the semi-wild Surinam Cherry that grows in Israel. [3]
Pitango Venture Capital Fund IV followed in 2004, and in 2007, Pitango V.[ citation needed ]
In 2010, with the support of the Israeli government, Pitango established the first fund in the country focused on investment in the Arab-Israeli sector, called Al-Bawader (Arabic for “early signs”). [4]
Company | Industry | Description | Initial Investment Date | Exit |
---|---|---|---|---|
Anobit | Semiconductors | flash memory controllers | 2006 | Acquired by Apple Inc. in 2012 for a reported $390 million. [11] |
InstallFree | Software | Application virtualization technology | 2006 | In December 2012, WatchDox Acquired InstallFree. [12] |
ClearForest | Software | Brokerage compliance, anti-money laundering, and fraud prevention | 2001 | Acquired by Reuters in 2007 for $25 Million [13] |
Radcom Ltd | Communications | Networking Infrastructure Equipment | 1993 | IPO on NASDAQ in 1997 |
Boxee | Consumer electronics | 2007 | Acquired by Samsung Electronics in 2013 for $30 million [14] | |
Check, Inc. | Mobile | Mobile Applications | 2007 | Acquired by Intuit in 2014 for $360 million. [15] |
AeroScout Industrial | Communications | RFID | 2000 | Acquired by Stanley Black & Decker in 2012. [16] |
BioLineRx | Biotechnology | 2003 | IPO on the Tel Aviv Stock Exchange. [17] [18] | |
dbMotion | Software | Health technology interoperability | 2005 | Acquired by Allscripts in 2013 for $235 million. [19] |
Mainsoft | Software | Network virtualization for software testing | 1993 | |
VocalTec | Telecommunication | VocalTec released the first Voice over Internet Protocol application | 1993 | IPO on NASDAQ 1996 |
Red Bend Software | Software | Mobile software management | 2000 | Acquired by Harman International Industries in 2015. [20] |
Radware | Communications | Advertising Data | 1997 | IPO on NASDAQ 1999 |
Traiana | Software | Post-trade processing, client servicing, and trading partner integration for financial institutions | 2004 | Acquired by ICAP in 2007 for $247 million. [21] |
EarlySense | Medical Technology | Medical device company | 2004 | IP acquired by Hillrom in 2021 for $30 million plus revenue share. [22] |
Index Ventures is a European venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security. Since its founding in 1996, the firm has invested in a number of companies and raised approximately $5.6 billion. Index Venture partners appear frequently on Forbes’ Midas List of the top tech investors in Europe and Israel.
MoreVC, formerly known as Israel Cleantech Ventures, is a venture capital firm founded in 2006 by Glen Schwaber, Jack Levy, and Meir Ukeles. It is a clean technology venture capital fund intent on providing growth capital to Israel's energy, water and environmental technology sectors. MoreVC receives funding from InnovFin, a company that provides equity investments to companies in their early stages of development.
Jerusalem Venture Partners (JVP) is an international venture capital firm founded in 1993. The fund specializes in investments in startup companies, focusing on digital media, enterprise software, semiconductors, data storage and cyber security, having raised close to $1.4 billion USD across nine funds. JVP is headquartered in Margalit Startup City Jerusalem with offices in Be'er Sheva, New York City and Paris.
Genesis Partners is an Israeli venture capital firm, founded in 1996 by Eddy Shalev and Eyal Kishon.
AppsFlyer is a SaaS mobile marketing analytics and attribution platform, headquartered in San Francisco, California.
Vertex Venture Holdings, also known as Vertex Holdings, is an investment holding company with a group of venture capital funds worldwide. A subsidiary of Temasek Holdings, the company focuses on venture capital investment opportunities in the information technology and healthcare markets through its global family of six direct investment venture funds. Vertex provides anchor funding and operational support to these funds. Each fund has its own General Partners and investment teams, focusing on different regional markets. Its six funds are based across Southeast Asia and India, United States of America, China and Israel.
Gili Raanan is an Israeli venture capitalist and one of the inventors of CAPTCHA, the WAF and many other inventions in the fields of application security and discovery. Raanan started Sanctum in 1997, and invented the first Web application firewall AppShield and the first Web application penetration testing software AppScan. He later started NLayers which was acquired by EMC Corporation pioneering the science of Application discovery and understanding. He is an investor and a General Partner at Sequoia Capital, the Founder of Cyberstarts, and was a board member at Adallom, Armis Security, Onavo, Moovit, Innovid (NYSE:CTV) and Snaptu.
YL Ventures is an American-Israeli venture capital firm that specializes in seed stage cybersecurity investments.
Monday.com is a cloud-based platform that allows users to create their own applications and project management software. The product was launched in 2014 and in July 2019, the company raised $150 million, based on a $1.9 billion valuation. The company went public in June 2021 and is based in Tel Aviv, Israel.
Molten Ventures, formerly Draper Esprit, is a venture capital firm, investing in high growth technology companies with global ambitions, with offices in London, Cambridge and Dublin. It is listed on the London Stock Exchange.
Nechemia ("Chemi") Jacob Peres Hebrew: חמי פרס is a venture capital and high-tech entrepreneur. He is co-founder and managing general partner of Pitango Venture Capital.
Fusion LA is a venture capital firm and an accelerator for Israeli startups in the United States. It was founded in 2017 and is headquartered in Santa Monica, California, United States.
TAU Ventures is a venture capital firm investing in early state startups in Israel. It was founded in 2018 by Tel Aviv University and Nimrod Cohen, and is headquartered in Tel Aviv, Israel.
Equitybee is an online platform for helping startup employees exercise their stock options and receive pre-IPO shares from privately held companies. It provides education about acquiring earned stock options and funding for acquiring the shares to startup employees. It was co-founded in 2017 by Oren Barzilai, Oded Golan, and Mody Radashkovich, and is based in Palo Alto, California, United States.
Shenzhen Capital Group Co., Ltd is a state-owned venture capital company based in Shenzhen, China. It is affiliated with the Shenzhen Government and its investments cover industries supported by national policies. According to South China Morning Post, from January 2019 to May 2020, it was the second most active venture capital firm in China.
The Samsung Catalyst Fund (SCF) is the evergreen venture capital fund of Samsung Electronics. The fund invests in deep technology, artificial intelligence and big data startups. The fund's headquarters are located in San Jose, California, with offices in Seoul, Tel Aviv, and Paris.
Michael Eisenberg is an American-born Israeli businessman, venture capitalist, and author.
Flint Capital is an international venture capital firm focused on startups in health technology, cybersecurity, consumer technology, and SaaS. Founded in 2013, the firm is headquartered in Boston, United States. Flint Capital's managing partners are Dmitry Smirnov, Sergey Gribov, and Andrew Gershfeld.
AI21 Labs is a Tel Aviv-based company specializing in Natural Language Processing (NLP), which develops AI systems that can understand and generate natural language.
AltaIR Capital is an international venture company founded by Igor Ryabenkiy. The company invests in startups in the US, Israel, and Europe.
Bioline Therapeutics today pulled off its initial public offering in Tel Aviv, raising NIS 211 million at a company valuation of NIS 494 million, making this the biggest flotation by a biotechnology company in local history.
BioLineRx Ltd. on Wednesday priced the largest ever initial public offering of a biomedical company on the Tel Aviv Stock Exchange, raising a total of NIS 211 million, or $50m.
{{cite web}}
: CS1 maint: archived copy as title (link)